Advanced Cell Technology To Present At Regenenerative Medicine Investor Day March 26, 2014
3/24/2014 8:44:23 AM
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology (ACTC) today announced that Edward Myles, Interim President, CFO & EVP of Corporate Development, will present at the 2nd Annual Regen Med Investor Day to be held Wednesday, March 26, 2014 in New York City. Organized by the Alliance for Regenerative Medicine (ARM) in partnership with leading financial firms Maxim Group and Piper Jaffray, this one-day investor conference focuses exclusively on the regenerative medicine and advanced therapies sector.
Help employers find you! Check out all the jobs and post your resume.
comments powered by